>

Syringe (prefilled, single chamber, 1/2 liquid, capped)

Q: Can I use the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon in a BioRender figure or scientific illustration?

Yes — the Syringe (prefilled, single chamber, 1/2 liquid, capped) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon for publication or presentations?

Yes — figures containing the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Syringe (prefilled, single chamber, 1/2 liquid, capped) - Editable icon of a capped syringe with single chamber pre-filled with 1/2 liquid

[{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560e7/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560e7/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560e8/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560e8/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560e9/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560e9/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560ea/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560ea/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560eb/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560eb/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560ec/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560ec/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560ed/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560ed/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560ee/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560ee/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560ef/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560ef/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f0/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f0/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f1/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f1/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f2/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f2/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f3/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f3/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f4/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f4/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f5/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f5/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f6/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f6/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f7/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f7/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f8/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f8/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560f9/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560f9/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560fa/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560fa/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560fb/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560fb/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560fc/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560fc/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560fd/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560fd/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560fe/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560fe/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f9560ff/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f9560ff/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956100/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956100/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956101/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956101/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956102/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956102/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956103/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956103/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956104/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956104/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956105/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956105/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956106/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956106/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956107/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956107/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956108/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956108/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f956109/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f956109/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f95610a/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f95610a/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f95610b/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f95610b/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f95610c/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f95610c/66798dd3666b6a652f9560a4.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66798e52666b6a652f95610d/66798dd3666b6a652f9560a4.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66798e52666b6a652f95610d/66798dd3666b6a652f9560a4.png"}]

Keywords

keyword text

syringe,prefilled,capped,single chamber,injection,medication,drug delivery,patient,Xolair,Leqvio,inclisiran,Entresto,sacubitril,valsartan,Kisqali,ribociclib,Cosentyx,secukinumab,Gilenya,fingolimod,Aimovig,erenumab,Lucentis,ranibizumab,Zolgensma,onasemnogene abeparvovec,allergic forms of asthma,nasal polyps,urticaria,hives,immunoglobulin E-mediated food allergy,healthcare,dosage,precise,sterile,ready-to-use,subcutaneous,intramuscular,intravenous,administration,packaging,preservation,needle,autoinjector,manual,disposable,reusable,compartmentalized,bifurcated,encapsulated,compartment,mixed,solution,lyophilized,reconstitution,activation,plunger,cartridge,ampoule,actuator,membrane,biological,pharmaceutical,chemistry,life sciences,medicine,therapeutics,diagnostics,research,clinical,pharmacology,biotechnology,biochemistry,molecular biology,immunology,oncology,endocrinology,rheumatology,cardiology,hematology,neurology,microbiology,virology,toxicology,dermatology,gastroenterology,nephrology,urology,pulmonology,gavage,1/2,half,liquid,half full,half filled,filled,full,proj-creative-abx-24q2,proj-creative-abx-24q2-[novartis],syringe

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Syringe (prefilled, single chamber, 1/2 liquid, capped) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Syringe (prefilled, single chamber, 1/2 liquid, capped) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon customizable in BioRender?

Most icons in BioRender, including the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon in their work?

BioRender users often use the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

Can I export figures that include the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon for publication or presentations?

Yes, figures containing the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Syringe (prefilled, single chamber, 1/2 liquid, capped) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

Syringe (prefilled, single chamber, 1/2 liquid, capped)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?